Orphan Medical slips after split panel

ORPH was off $1.075 to $11.25 on Thursday after the FDA's Peripheral and Central Nervous System Drugs Advisory Committee on Wednesday voted that ORPH's Xyrem gamma hydroxy butyrate was effective in tr...